Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Apricitabine

Generic Name: Apricitabine

Drug Type: Small Molecule

Chemical Formula: C_₈H_₁₁N_₃O_₃S

CAS Number: 160707-69-7

Unique Ingredient Identifier: K1YX059ML1

Overview

Apricitabine has been used in trials studying the treatment of HIV Infections.

Background

Apricitabine has been used in trials studying the treatment of HIV Infections.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Phase 3

Withdrawn

Posted: 2008/05/29

Sponsor:

Avexa

ID:NCT00686270

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

Phase 2

Terminated

Posted: 2008/02/12

Sponsor:

Avexa

ID:NCT00612898

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

Phase 2

Completed

Posted: 2006/08/24

Sponsor:

Avexa

ID:NCT00367952

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

Phase 1

Completed

Posted: 2006/07/14

Sponsor:

Avexa

ID:NCT00352066

A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects

Phase 1

Completed

Posted: 2006/06/08

Sponsor:

Avexa

ID:NCT00334659

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy